QLETLI Trademark

Trademark Overview


On Wednesday, November 21, 2018, a trademark application was filed for QLETLI with the United States Patent and Trademark Office. The USPTO has given the QLETLI trademark a serial number of 79260638. The federal status of this trademark filing is REGISTERED as of Tuesday, April 7, 2020. This trademark is owned by Bio-Thera Solutions, Ltd.. The QLETLI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; chemical preparations for pharmaceutical purposes for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; Biological preparations for medical purposes for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; injectable pharmaceutical preparations for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; medicines for use in humans for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases
qletli

General Information


Serial Number79260638
Word MarkQLETLI
Filing DateWednesday, November 21, 2018
Status700 - REGISTERED
Status DateTuesday, April 7, 2020
Registration Number6026183
Registration DateTuesday, April 7, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 21, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; chemical preparations for pharmaceutical purposes for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; Biological preparations for medical purposes for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; injectable pharmaceutical preparations for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; medicines for use in humans for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 18, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBio-Thera Solutions, Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressScience City, Guangzhou
CN

Party NameBio-Thera Solutions, Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressScience City, Guangzhou
CN

Party NameBio-Thera Solutions, Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressScience City, Guangzhou
CN

Trademark Events


Event DateEvent Description
Saturday, August 29, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, August 12, 2020FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, August 12, 2020FINAL DISPOSITION PROCESSED
Tuesday, July 7, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 7, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, January 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 13, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 13, 2019EXAMINER'S AMENDMENT ENTERED
Friday, December 13, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, December 13, 2019EXAMINERS AMENDMENT E-MAILED
Friday, December 13, 2019EXAMINERS AMENDMENT -WRITTEN
Friday, December 13, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 13, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 13, 2019ASSIGNED TO LIE
Wednesday, December 4, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 2, 2019REFUSAL PROCESSED BY IB
Tuesday, July 16, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, July 16, 2019REFUSAL PROCESSED BY MPU
Monday, June 24, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, June 23, 2019NON-FINAL ACTION WRITTEN
Saturday, June 22, 2019APPLICATION FILING RECEIPT MAILED
Tuesday, June 18, 2019ASSIGNED TO EXAMINER
Tuesday, June 18, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 13, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB